Literature DB >> 29597076

Genome engineering for CNS injury and disease.

Jennifer Pardieck1, Shelly Sakiyama-Elbert2.   

Abstract

Recent developments in genome engineering methods have advanced our knowledge of central nervous system (CNS) function in both normal health and following disease or injury. This review discusses current literature using gene editing tools in CNS disease and injury research, such as improving viral-mediated targeting of cell populations, generating new methods for genome editing, reprogramming cells into CNS cell types, and using organoids as models of development and disease. Readers may gain inspiration for continuing research into new genome engineering methods and for therapies for CNS applications.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29597076      PMCID: PMC6082714          DOI: 10.1016/j.copbio.2018.03.001

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  35 in total

1.  Reprogramming of somatic cells: iPS and iN cells.

Authors:  Vania Broccoli
Journal:  Prog Brain Res       Date:  2017-02-06       Impact factor: 2.453

2.  Rabies Virus CVS-N2c(ΔG) Strain Enhances Retrograde Synaptic Transfer and Neuronal Viability.

Authors:  Thomas R Reardon; Andrew J Murray; Gergely F Turi; Christoph Wirblich; Katherine R Croce; Matthias J Schnell; Thomas M Jessell; Attila Losonczy
Journal:  Neuron       Date:  2016-01-21       Impact factor: 17.173

3.  MicroRNAs Induce a Permissive Chromatin Environment that Enables Neuronal Subtype-Specific Reprogramming of Adult Human Fibroblasts.

Authors:  Daniel G Abernathy; Woo Kyung Kim; Matthew J McCoy; Allison M Lake; Rebecca Ouwenga; Seong Won Lee; Xiaoyun Xing; Daofeng Li; Hyung Joo Lee; Robert O Heuckeroth; Joseph D Dougherty; Ting Wang; Andrew S Yoo
Journal:  Cell Stem Cell       Date:  2017-09-07       Impact factor: 24.633

4.  Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B.

Authors:  Kasey L Jackson; Robert D Dayton; Benjamin E Deverman; Ronald L Klein
Journal:  Front Mol Neurosci       Date:  2016-11-04       Impact factor: 5.639

5.  Cre Fused with RVG Peptide Mediates Targeted Genome Editing in Mouse Brain Cells In Vivo.

Authors:  Zhiyuan Zou; Zhaolin Sun; Pan Li; Tao Feng; Sen Wu
Journal:  Int J Mol Sci       Date:  2016-12-14       Impact factor: 5.923

6.  Differentiation of human and murine induced pluripotent stem cells to microglia-like cells.

Authors:  Hetal Pandya; Michael J Shen; David M Ichikawa; Andrea B Sedlock; Yong Choi; Kory R Johnson; Gloria Kim; Mason A Brown; Abdel G Elkahloun; Dragan Maric; Colin L Sweeney; Selamawit Gossa; Harry L Malech; Dorian B McGavern; John K Park
Journal:  Nat Neurosci       Date:  2017-03-02       Impact factor: 24.884

7.  Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain.

Authors:  Benjamin E Deverman; Piers L Pravdo; Bryan P Simpson; Sripriya Ravindra Kumar; Ken Y Chan; Abhik Banerjee; Wei-Li Wu; Bin Yang; Nina Huber; Sergiu P Pasca; Viviana Gradinaru
Journal:  Nat Biotechnol       Date:  2016-02-01       Impact factor: 54.908

8.  Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes.

Authors:  Waseem K Raja; Alison E Mungenast; Yuan-Ta Lin; Tak Ko; Fatema Abdurrob; Jinsoo Seo; Li-Huei Tsai
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

9.  Efficient derivation of microglia-like cells from human pluripotent stem cells.

Authors:  Julien Muffat; Yun Li; Bingbing Yuan; Maisam Mitalipova; Attya Omer; Sean Corcoran; Grisilda Bakiasi; Li-Huei Tsai; Patrick Aubourg; Richard M Ransohoff; Rudolf Jaenisch
Journal:  Nat Med       Date:  2016-09-26       Impact factor: 53.440

10.  CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector.

Authors:  Giridhar Murlidharan; Kensuke Sakamoto; Lavanya Rao; Travis Corriher; Dan Wang; Guangping Gao; Patrick Sullivan; Aravind Asokan
Journal:  Mol Ther Nucleic Acids       Date:  2016-07-19       Impact factor: 10.183

View more
  2 in total

Review 1.  Recent advances in nanotherapeutic strategies for spinal cord injury repair.

Authors:  Young Hye Song; Nikunj K Agrawal; Jonathan M Griffin; Christine E Schmidt
Journal:  Adv Drug Deliv Rev       Date:  2018-12-22       Impact factor: 15.470

Review 2.  Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical Assessment.

Authors:  Samantha L Eaton; Fraser Murdoch; Nina M Rzechorzek; Gerard Thompson; Claudia Hartley; Benjamin Thomas Blacklock; Chris Proudfoot; Simon G Lillico; Peter Tennant; Adrian Ritchie; James Nixon; Paul M Brennan; Stefano Guido; Nadia L Mitchell; David N Palmer; C Bruce A Whitelaw; Jonathan D Cooper; Thomas M Wishart
Journal:  Cells       Date:  2022-08-25       Impact factor: 7.666

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.